{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T20:43:41Z","timestamp":1770497021560,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10812-x","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T16:08:25Z","timestamp":1743437305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of QuantiFERON TB gold plus among TB household contacts in high incidence settings"],"prefix":"10.1186","volume":"25","author":[{"given":"Sophie","family":"Nalukwago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Chervenak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AnnaRitah","family":"Namuganga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LaShaunda L.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Nsereko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Henry","family":"Boom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harriet","family":"Mayanja-Kizza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"10812_CR1","unstructured":"Global Tuberculosis reporT 2022. 2022. Available from: http:\/\/apps.who.int\/bookorders"},{"key":"10812_CR2","doi-asserted-by":"crossref","unstructured":"Sharma SK, Vashishtha R, Chauhan LS, Sreenivas V, Seth D. Comparison of TST and IGRA in diagnosis of latent tuberculosis infection in a high TB-burden setting. PLoS ONE. 2017;12(1).","DOI":"10.1371\/journal.pone.0169539"},{"issue":"1","key":"10812_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","volume":"27","author":"M Pai","year":"2014","unstructured":"Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, Oxlade O, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev. 2014;27(1):3\u201320.","journal-title":"Clin Microbiol Rev"},{"key":"10812_CR4","unstructured":"Qiagen. QuantiFERON TB gold (QFT) ELISA package insert. Qiagen Leiden Ger. 2013. http:\/\/www.quantiferon.com\/irm\/content\/PI\/QFT\/2PK\/UK.pdf. Accessed, 25 August 2022"},{"key":"10812_CR5","doi-asserted-by":"crossref","unstructured":"Lewinsohn DM, Swarbrick GM, Cansler ME, Null MD, Rajaraman V, Frieder MM et al. Human Mycobacterium tuberculosis CD8 T cell antigens\/epitopes identified by a proteomic peptide library. PLoS ONE. 2013;8(6).","DOI":"10.1371\/journal.pone.0067016"},{"issue":"2","key":"10812_CR6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1164\/rccm.201107-1355OC","volume":"185","author":"C Lancioni","year":"2012","unstructured":"Lancioni C, Nyendak M, Kiguli S, Zalwango S, Mori T, Mayanja-Kizza H, et al. CD8\u2009+\u2009T cells provide an Immunologic signature of tuberculosis in young children. Am J Respir Crit Care Med. 2012;185(2):206\u201312.","journal-title":"Am J Respir Crit Care Med"},{"key":"10812_CR7","unstructured":"Qiagen. QuantiFERON-TB Gold Plus (QFT-Plus) ELISA package insert. 2023."},{"issue":"12","key":"10812_CR8","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.21037\/jtd.2019.12.11","volume":"11","author":"JY Hong","year":"2019","unstructured":"Hong JY, Park SY, Kim A, Cho SN, Hur YG. Comparison of QFT-Plus and QFT-GIT tests for diagnosis of M. tuberculosis infection in immunocompetent Korean subjects. J Thorac Dis. 2019;11(12):5210\u20137.","journal-title":"J Thorac Dis"},{"key":"10812_CR9","doi-asserted-by":"publisher","unstructured":"Moon HW, Gaur RL, Shu-Hwa Tien S, Spangler M, Pai M, Banaei N. Evaluation of QuantiFERON-TB gold-plus in health care workers in a low-incidence setting. J Clin Microbiol. 2017;55(6). https:\/\/doi.org\/10.1128\/JCM.02498-16.","DOI":"10.1128\/JCM.02498-16"},{"key":"10812_CR10","doi-asserted-by":"crossref","unstructured":"Won D, Park JY, Kim HS, Park Y. Comparative results of QuantiFERON-TB gold in-tube and QuantiFERON-TB gold plus assays for detection of tuberculosis infection in clinical samples. J Clin Microbiol. 2020;58(4).","DOI":"10.1128\/JCM.01854-19"},{"key":"10812_CR11","doi-asserted-by":"crossref","unstructured":"Xu Y, Yang Q, Zhou J, Zhou F, Hezhang Y, Gao Y et al. Comparison of QuantiFERON-TB gold In-Tube and QuantiFERON-TB gold-Plus in the diagnosis of Mycobacterium tuberculosis infections in immunocompromised patients: a Real-World study. Microbiol Spectr. 2022;10(2).","DOI":"10.1128\/spectrum.01870-21"},{"issue":"5","key":"10812_CR12","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","volume":"48","author":"L Barcellini","year":"2016","unstructured":"Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, et al. First evaluation of QuantiFERON-TB gold plus performance in contact screening. Eur Respir J. 2016;48(5):1411\u20139.","journal-title":"Eur Respir J"},{"issue":"4","key":"10812_CR13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/tropicalmed9040081","volume":"9","author":"J Gutierrez","year":"2024","unstructured":"Gutierrez J, Nsereko M, Malone LL, Mayanja-Kizza H, Kisingo H, Boom WH, Bark CM, Stein CM. Capturing recent Mycobacterium tuberculosis infection by tuberculin skin test vs. Interferon-Gamma release assay. Trop Med Infect Dis. 2024;9(4):81.","journal-title":"Trop Med Infect Dis"},{"key":"10812_CR14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JRKG Landis","year":"1977","unstructured":"Landis JRKG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159\u201374.","journal-title":"Biometrics"},{"issue":"3","key":"10812_CR15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22(3):276\u201382.","journal-title":"Biochem Med"},{"key":"10812_CR16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"327","author":"JMAD Bland","year":"1986","unstructured":"Bland JMAD. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;327:307\u201310.","journal-title":"Lancet"},{"key":"10812_CR17","doi-asserted-by":"crossref","unstructured":"Ma N, Zalwango S, Malone LSL, Nsereko M, Wampande EM, Thiel BA et al. Clinical and epidemiological characteristics of individuals resistant to M. tuberculosis infection in a longitudinal TB household contact study in Kampala, Uganda. BMC Infect Dis. 2014;14(1).","DOI":"10.1186\/1471-2334-14-352"},{"key":"10812_CR18","unstructured":"R Core Team. A language and Environment for Statistical Computing. R Foundation for Statistical Computing. Viienna, Austria. R-project.org. 2023."},{"key":"10812_CR19","doi-asserted-by":"crossref","unstructured":"Schablon A, Nienhaus A, Ringshausen FC, Preisser AM, Peters C. Occupational screening for tuberculosis and the use of a borderline zone for interpretation of the IGRA in German healthcare workers. PLoS ONE. 2014;9(12).","DOI":"10.1371\/journal.pone.0115322"},{"issue":"5","key":"10812_CR20","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1164\/rccm.201409-1704OC","volume":"191","author":"JR Andrews","year":"2015","unstructured":"Andrews JR, Hatherill M, Mahomed H, Hanekom WA, Campo M, Hawn TR, et al. The dynamics of QuantiFERON-TB gold in-Tube conversion and reversion in a cohort of South African adolescents. Am J Respir Crit Care Med. 2015;191(5):584\u201391.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10812_CR21","doi-asserted-by":"crossref","first-page":"690","DOI":"10.5588\/ijtld.16.0764","volume":"21","author":"L Telisinghe","year":"2017","unstructured":"Telisinghe L, Amofa-Sekyi M, Maluzi K, Kaluba-Milimo D, Cheeba-Lengwe M, Chiwele K, et al. The sensitivity of the QuantiFERON\u00ae-TB gold plus assay in Zambian adults with active tuberculosis. Int J Tuberculosis Lung Disease. 2017;21(6):690\u20136.","journal-title":"Int J Tuberculosis Lung Disease"},{"issue":"12","key":"10812_CR22","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.jiac.2021.08.003","volume":"27","author":"JK Lee","year":"2021","unstructured":"Lee JK, Lee HW, Heo EY, Yim JJ, Kim DK. Comparison of quantiferon -TB gold plus and quantiferon-TB gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study. Infect Chemother. 2021;27(12):1694\u20139.","journal-title":"Infect Chemother"},{"key":"10812_CR23","doi-asserted-by":"crossref","unstructured":"Van Zyl-Smit RN, Zwerling A, Dheda K, Pai M. Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: A systematic review. 4, PLoS ONE. 2009.","DOI":"10.1371\/journal.pone.0008517"},{"issue":"5","key":"10812_CR24","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1164\/rccm.201704-0817OC","volume":"196","author":"E Nemes","year":"2017","unstructured":"Nemes E, Rozot V, Geldenhuys H, Bilek N, Mabwe S, Abrahams D, et al. Optimization and interpretation of serial quantiferon testing to measure acquisition of Mycobacterium tuberculosis infection. Am J Respir Crit Care Med. 2017;196(5):638\u201348.","journal-title":"Am J Respir Crit Care Med"},{"key":"10812_CR25","first-page":"3","volume-title":"Use of interferon-gamma release assays in support of TB diagnosis","author":"European Centre for Disease Prevention and Control","year":"2011","unstructured":"European Centre for Disease Prevention and Control. Use of interferon-gamma release assays in support of TB diagnosis. Stockholm: ECDC; 2011. pp. 3\u201338."},{"issue":"8","key":"10812_CR26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cmi.2016.05.006","volume":"22","author":"H Hoffmann","year":"2016","unstructured":"Hoffmann H, Avsar K, G\u00f6res R, Mavi SC, Hofmann-Thiel S. Equal sensitivity of the new generation QuantiFERON-TB gold plus in direct comparison with the previous test version QuantiFERON-TB gold IT. Clin Microbiol Infect. 2016;22(8):701\u20133.","journal-title":"Clin Microbiol Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10812-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10812-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10812-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T16:09:29Z","timestamp":1743437369000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10812-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10812"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10812-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Publication of these data was approved by the Institutional Ethics Review Board (IRB) of the Makerere University School of Biomedical Sciences and the Uganda National Council for Science and Technology. Every procedure was carried out in compliance with the of Helsinki and all applicable rules and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"447"}}